comparemela.com

Latest Breaking News On - Acquisitions mergers shareholdings - Page 4 : comparemela.com

Reckitt Benckiser profits slump on lower sales and Middle East accounting issue

The Durex owner saw its sales volumes plunge following its decision to hike prices by 7.8% over 2023

United kingdomTaylor wimpeyReckitt colmanJames jonesKris lichtReckitt benckiser group onReckitt benckiser groupMiddle eastReckitt benckiserMarkets authorityArticle normalRespiratory allergy treatmentsDetergent cleaning productsHealthcare life sciencesConsumer goodsSpecialized drugs medications

Aeon Co Plans to Merge Japan Drugstore Unit Welcia with Rival Tsuruha

By Kosaku Narioka Aeon Co. plans to merge its Japanese drugstore unit Welcia Holdings with rival Tsuruha Holdings in a bid to solidify its presence in the.

Kosaku nariokaWelcia holdingsTsuruha holdingsAeon coHong kong basedOasis managementArticle normalFinancial investment servicesInvestment bankingBanking creditFinancial servicesInvesting securitiesCorporate strategy planningOwnership changesAcquisitions mergers shareholdingsCapacity facilities

Aeon Co Plans to Merge Japan Drugstore Unit Welcia With Rival Tsuruha -- Update

By Kosaku Narioka Aeon Co. plans to merge its Japanese drugstore unit Welcia Holdings with rival Tsuruha Holdings in a bid to solidify its presence in the.

Kosaku nariokaAeon coWelcia holdingsTsuruha holdingsHong kong basedOasis managementArticle normalFinancial investment servicesInvestment bankingBanking creditFinancial servicesInvesting securitiesCorporate strategy planningOwnership changesAcquisitions mergers shareholdingsCapacity facilities

Aeon Co Plans to Merge Japan Drugstore Unit Welcia With Rival Tsuruha -- 2nd Update

By Kosaku Narioka Aeon Co. plans to merge its Japanese drugstore unit Welcia Holdings with rival Tsuruha Holdings in a bid to solidify its presence in the.

Kosaku nariokaAeon coWelcia holdingsTsuruha holdingsHong kong basedOasis managementArticle normalFinancial investment servicesInvestment bankingBanking creditFinancial servicesInvesting securitiesCorporate strategy planningOwnership changesAcquisitions mergers shareholdingsAcquisitions mergers

Crinetics Pharma Shares Hit 52-Week High After Oversubscribed Private Placement

By Chris Wack Crinetics Pharmaceuticals shares were up 15% at $46.60 after the company agreed to sell 8.3 million shares at a price of $42 a share to a.

Chris wackCrinetics pharmaceuticalsAdage capital partnersDriehaus capital managementFirst light assetArticle normalTrusts funds financial vehiclesFinancial investment servicesPortfolio fund asset managementHealthcare life sciencesAlternative investmentsFinancial servicesHedge fundsInvesting securitiesCorporate fundingOwnership changes

vimarsana © 2020. All Rights Reserved.